These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2383160)

  • 1. Day-to-day variability of serum cholesterol, triglyceride, and high-density lipoprotein cholesterol levels. Impact on the assessment of risk according to the National Cholesterol Education Program guidelines.
    Bookstein L; Gidding SS; Donovan M; Smith FA
    Arch Intern Med; 1990 Aug; 150(8):1653-7. PubMed ID: 2383160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma lipoprotein levels as predictors of cardiovascular death in women.
    Bass KM; Newschaffer CJ; Klag MJ; Bush TL
    Arch Intern Med; 1993 Oct; 153(19):2209-16. PubMed ID: 8215724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular risk factors and lipoprotein profile in French Canadians with premature CAD: impact of the National Cholesterol Education Program II.
    McNicoll S; Latour Y; Rondeau C; Bouthillier D; Davignon J; Genest J
    Can J Cardiol; 1995 Feb; 11(2):109-16. PubMed ID: 7866933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A tertiary care hospital-based study of conventional risk factors including lipid profile in proven coronary artery disease.
    Goel PK; Bharti BB; Pandey CM; Singh U; Tewari S; Kapoor A; Garg N; Sinha N
    Indian Heart J; 2003; 55(3):234-40. PubMed ID: 14560932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of high plasma triglyceride combined with low HDL-C levels and its association with smoking, hypertension, obesity, diabetes, sedentariness and LDL-C levels in the Canadian population. Canadian Heart Health Surveys Research Group.
    Connelly PW; Petrasovits A; Stachenko S; MacLean DR; Little JA; Chockalingam A
    Can J Cardiol; 1999 Apr; 15(4):428-33. PubMed ID: 10322252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial).
    Goldenberg I; Benderly M; Sidi R; Boyko V; Tenenbaum A; Tanne D; Behar S
    Am J Cardiol; 2009 Jan; 103(1):41-5. PubMed ID: 19101227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of currently recommended pediatric dyslipidemia classifications in predicting dyslipidemia in adulthood: evidence from the Childhood Determinants of Adult Health (CDAH) study, Cardiovascular Risk in Young Finns Study, and Bogalusa Heart Study.
    Magnussen CG; Raitakari OT; Thomson R; Juonala M; Patel DA; Viikari JS; Marniemi J; Srinivasan SR; Berenson GS; Dwyer T; Venn A
    Circulation; 2008 Jan; 117(1):32-42. PubMed ID: 18071074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An evaluation of two compact analyzers used for lipid analysis.
    McKenney JM; Fary DF; Miller G; Proctor JD; Chinchili VM
    J Fam Pract; 1993 May; 36(5):526-33. PubMed ID: 8482937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of a province-wide quality assurance program assessing the accuracy of cholesterol, triglycerides, and high-density lipoprotein cholesterol measurements and calculated low-density lipoprotein cholesterol in Ontario, using fresh human serum.
    McQueen MJ; Henderson AR; Patten RL; Krishnan S; Wood DE; Webb S
    Arch Pathol Lab Med; 1991 Dec; 115(12):1217-22. PubMed ID: 1768212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of childhood low-density lipoprotein cholesterol level in predicting adult dyslipidemia and other cardiovascular risks. The Bogalusa Heart Study.
    Bao W; Srinivasan SR; Wattigney WA; Bao W; Berenson GS
    Arch Intern Med; 1996 Jun; 156(12):1315-20. PubMed ID: 8651840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lability of serum low-density lipoprotein cholesterol levels during screening in subgroup of Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) cohort.
    Clearfield MB; Weis SE; Willis JM; Vasenius KA; McConathy WJ
    J Am Osteopath Assoc; 2002 Jul; 102(7):377-84. PubMed ID: 12138952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lowering LDL cholesterol in adults: a prospective, community-based practice initiative.
    Coodley GO; Jorgensen M; Kirschenbaum J; Sparks C; Zeigler L; Albertson BD
    Am J Med; 2008 Jul; 121(7):604-10. PubMed ID: 18538295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of 2 homogeneous high-density lipoprotein cholesterol assays.
    Hoang MP; Hirany SV; Parupia J; Devaraj S; Jialal I
    Arch Pathol Lab Med; 1998 Nov; 122(11):1005-9. PubMed ID: 9822130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of the precision of the Friedewald's formula for the calculation of low density lipoprotein cholesterol concentration in serum].
    Chotkowska E; Kurjata P; Kupść W
    Pol Merkur Lekarski; 2001 Oct; 11(64):348-51. PubMed ID: 11770317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of simvastatin only or in combination with continuous combined hormone replacement therapy on serum lipid levels in hypercholesterolaemic post-menopausal women.
    Fak AS; Erenus M; Tezcan H; Caymaz O; Atagündüz P; Oktay S; Oktay A
    Eur Heart J; 2000 Feb; 21(3):190-7. PubMed ID: 10639300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlates and consequences of diffuse atherosclerosis in men with coronary heart disease. Veterans Affairs High-Density Lipoprotein Intervention Trial Study Group.
    Wilt TJ; Rubins HB; Collins D; O'Connor TZ; Rutan GH; Robins SJ
    Arch Intern Med; 1996 Jun; 156(11):1181-8. PubMed ID: 8639012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of predispensed reagent and noncentrifugation methods for high-density lipoprotein cholesterol measurement.
    Zhang DJ; LaRue S; Miller WG; Cole TG
    Arch Pathol Lab Med; 1997 Sep; 121(9):938-47. PubMed ID: 9302925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma lipids and lipoprotein reference values, and the prevalence of dyslipoproteinemia in Canadian adults. Canadian Heart Health Surveys Research Group.
    MacLean DR; Petrasovits A; Connelly PW; Joffres M; O'Connor B; Little JA
    Can J Cardiol; 1999 Apr; 15(4):434-44. PubMed ID: 10322253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Achieving vascular risk factor targets: a survey of a London general practice.
    Levine AP; Mikhailidis DP; Moross T; Benson K; Gor M
    Angiology; 2008; 59(1):36-46. PubMed ID: 18319220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk determination of dyslipidemia in populations characterized by low levels of high-density lipoprotein cholesterol.
    Bersot TP; Pépin GM; Mahley RW
    Am Heart J; 2003 Dec; 146(6):1052-9. PubMed ID: 14660998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.